Athos Capital Ltd Quant / Systematic

Location: Hong Kong

CIK: 0001681662 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 13, 2020

Total Value: $146M (100.0% shares, 0.0% debt)

Holdings (21)

58 COM INC 23.9%
Value $34.96M Shares 648,046 Est. Cost $53.94 Unrealized
CHINA BIOLOGIC PRODS HLDGS I 18.8%
Value $27.57M Shares 269,832 Est. Cost $101.47 Unrealized
TIFFANY & CO NEW 14.7%
Value $21.51M Shares 176,406 Est. Cost $129.02 Unrealized
JD JD.COM INC 6.9%
Value $10.04M Shares 166,858 Est. Cost $60.18 Unrealized
BHP GROUP PLC 6.1%
Value $8.878M Shares 215,750 Est. Cost $30.34 Unrealized
WRIGHT MED GROUP N V 5.8%
Value $8.515M Shares 286,524 Est. Cost $29.66 Unrealized
CAESARS ENTMT CORP 4.8%
Value $6.987M Shares 576,022 Est. Cost $12.13 Unrealized
BABA ALIBABA GROUP HLDG LTD 3.7%
Value $5.41M Shares 25,081 Est. Cost $215.70 Unrealized
SONY SONY CORP 3.4%
Value $4.977M Shares 72,000 Est. Cost $63.44 Unrealized
HSBC HSBC HLDGS PLC 2.4%
Value $3.511M Shares 150,504 Est. Cost $28.89 Unrealized
EVRG EVERGY INC 1.6%
Value $2.372M Shares 40,000 Est. Cost $47.34 Unrealized 0.0%
TAUBMAN CTRS INC 1.6%
Value $2.341M Shares 62,000 Est. Cost $37.76 Unrealized
CHINA MOBILE LIMITED 1.5%
Value $2.183M Shares 64,900 Est. Cost $33.64 Unrealized
TM TOYOTA MOTOR CORP 1.1%
Value $1.651M Shares 13,143 Est. Cost $125.62 Unrealized
NTES NETEASE INC 1.1%
Value $1.609M Shares 3,748 Est. Cost $429.30 Unrealized
SMFG SUMITOMO MITSUI FINL GROUP I 0.8%
Value $1.124M Shares 200,000 Est. Cost $5.62 Unrealized
TAK TAKEDA PHARMACEUTICAL CO LTD 0.7%
Value $1.076M Shares 60,000 Est. Cost $17.93 Unrealized
GNW GENWORTH FINL INC 0.5%
Value $741K Shares 320,800 Est. Cost $3.15 Unrealized 0.0%
GRIDSUM HLDG INC 0.4%
Value $616K Shares 879,192 Est. Cost $1.92 Unrealized
CENTRAL EUROPEAN MEDIA ENTRP 0.1%
Value $176K Shares 49,725 Est. Cost $3.54 Unrealized
BRISTOL-MYERS SQUIBB CO 0.1%
Value $173K Shares 48,283 Est. Cost $3.01 Unrealized